Nationally, 25% of patients admitted to the hospital from the emergency department have to wait 4 hours or more for a bed during nonpeak months.

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

The sodium chloride 0.9 percent injection shortage is resolved, and it will be removed from the FDA Drug Shortage Database; facilities are advised to use FDA-approved products when available. The FDA ...

With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.

Among patients with chronic hepatitis C virus (HCV), post-sustained virologic response (SVR) hepatocellular carcinoma (HCC) risk is significantly higher with metabolic dysfunction-associated steatotic ...

Physician attire impacts patients' perceptions of professionalism, trust, and communication, but perceptions are highly context-dependent.

Respiratory syncytial virus vaccine uptake was low among older veterans, with disparities observed across demographic and social risk factors.

Black and Hispanic children were disproportionately more likely to experience severe COVID-19 hospitalization compared with White and Asian or Pacific Islander children.

An estimated 440 deaths from January 5 to February 1, 2025, in Los Angeles County were attributable to the Los Angeles wildfires.

Inflammatory pathways that contribute to asthma exacerbations have been identified in children with eosinophilic asthma receiving mepolizumab.

Most individuals living in underserved communities believe that dermatologic side effects from anticancer therapies occur at high rates.

Subspecialization in oncology is increasing, but varies widely across cancer types and regions, according to a study published online Aug. 12 in the Annals of Internal Medicine. Rene Karadakic, Ph.D., ...